Phase I Study of VLPDEN-02 Dengue Vaccine in Healthy Adults
Phase I Study of VLPDEN-02 Dengue Vaccine in Healthy Adults
Not yet recruiting · NCT07831473 · Registry updated 2026-09-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase I Study of VLPDEN-02 Dengue Vaccine in Healthy Adults | Flaviviridae infectious disease, Flavivirus Infections, Infections, Mosquito-Borne Diseases, RNA Virus Infections, arbovirus infection, dengue disease, vector-borne disease, viral hemorrhagic fever, viral infectious disease | Not yet recruiting | Phase 1 | 2026-09-21 | NCT07831473 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Global Health Innovative Technology Fund | 2 |
| VLP Therapeutics | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Johns Hopkins University | Baltimore | United States | 49 |